Scientists are using advanced computer programs to design better therapeutic antibodies. These antibodies are crucial for treating various diseases, but sometimes, the patient’s body sees them as foreign and...
Scientists have been working to improve therapeutic antibodies, which are important tools for treating diseases like cancer and autoimmune disorders. A key challenge is making these antibodies less likely...
CD99 is highly expressed in T cell acute lymphoblastic leukemia (T-ALL), a type of cancer. One promising treatment involves a mouse monoclonal antibody against CD99 called mAb MT99/3, which...
A new humanized antibody, derived from a mouse antibody, has been engineered to target CD99, a protein overexpressed in T-cell acute lymphoblastic leukemia (T-ALL) and T-lymphoblastic lymphoma (T-LBL). The...
A follow-up study on 50 adults investigated the impact of PM2.5 exposure on ocular health. Samples were collected before and after the high PM2.5 season, utilizing data from the...
Scientists have developed a new type of immunotherapy that uses genetically modified natural killer (NK) cells to target and destroy cancer cells. NK cells are a type of immune...
Scientists have engineered immune cells to be more effective at fighting T-cell leukemia. They modified these cells to lack a protein called CD147, which altered their behavior and showed...
CD99, which is highly expressed in T-acute lymphoblastic leukemia (T-ALL), could be an effective target for antibody-based treatment. In this study, researchers used a monoclonal antibody against CD99 called...
Scientists have created a modified version of an antibody that can precisely target a protein involved in cancer growth and spread. The original antibody was derived from a mouse,...